Home Cart Sign in  
Chemical Structure| 1458-63-5 Chemical Structure| 1458-63-5

Structure of 1458-63-5

Chemical Structure| 1458-63-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1458-63-5 ]

CAS No. :1458-63-5
Formula : C8H16ClN
M.W : 161.67
SMILES Code : ClCCCN1CCCCC1
MDL No. :MFCD00044515
InChI Key :HDDNBUNZJIQDBQ-UHFFFAOYSA-N
Pubchem ID :79625

Safety of [ 1458-63-5 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H319
Precautionary Statements:P305+P351+P338

Application In Synthesis of [ 1458-63-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1458-63-5 ]

[ 1458-63-5 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 1458-63-5 ]
  • [ 13472-79-2 ]
  • 5-iodo-1-(3-piperidin-1-yl-propyl)-1<i>H</i>-pyridin-2-one [ No CAS ]
  • 2
  • [ 1458-63-5 ]
  • [ 190900-21-1 ]
  • [ 955027-65-3 ]
YieldReaction ConditionsOperation in experiment
90% A) 5-Oxo-4-(3-piperidin-1-yl-propyl)-[1,4]diazepane-1-carboxylic Acid tert-butyl ester; A solution of 8.52 g (39.75 mmol) of <strong>[190900-21-1]5-oxo-[1,4]diazepane-1-carboxylic acid tert-butyl ester</strong> in 200 ml of DMA was treated at 0° C. with 2.60 g (59.6 mmol) of NaH (55percent dispersion in oil) in small portions. The reaction was stirred 1 h at this temperature, then the free 1-(3-chloropropyl)piperidine in 200 ml toluene was dropped in [49.62 g (250.42 mmol, 6.3 eq.) 1-(3-chloropropyl)piperidine hydrochloride were dissolved in 262 ml of 1 M aq. NaOH solution and extracted with toluene (200 ml). The organic phase was dried over Na2SO4]. The reaction was warmed up to RT and stirred overnight. After 2 h at 50° C. and cooling to RT, the reaction was neutralized with water (50 ml), evaporated and then dissolved in sat. aq. NaHCO3/Et2O. After reextraction with Et2O, the organic phase was dried (Na2SO4), evaporated and crystallized from pentane to yield 12.08 g (90percent) of the title compound as white crystals. MS: 340.2 (MH+).
90% A) 5-Oxo-4-(3-piperidin-1-yl-propyl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester; A solution of 8.52 g (39.75 mmol) of <strong>[190900-21-1]5-oxo-[1,4]diazepane-1-carboxylic acid tert-butyl ester</strong> in 200 ml of N,N-dimethylacetamide was treated at 0° C. with 2.60 g (59.62 mmol) of NaH (55percent in oil) in small portions. The reaction was stirred 1 h at this temperature, then the free 1-(3-chloropropyl)piperidine in 200 ml toluene was dropped in [49.6 g (250 mmol, 6.3 eq.) 1-(3-chloropropyl)piperidine hydrochloride were dissolved in 262 ml of 1 M aq. sodium hydroxide solution and extracted with toluene (200 ml). The organic phase was dried over Na2SO4]. The reaction was warmed up to room temperature and stirred over night. After 2 h at 50° C. and cooling to room temperature, the reaction was neutralized with water (50 ml), evaporated and then dissolved in sat. aq. sodium hydrogencarbonate solution/diethyl ether. After reextraction with diethyl ether, the organic phase was dried (Na2SO4), evaporated and crystallized from pentane to yield 12.08 g (90percent) of the title compound as white crystals. MS: 340.2 (MH+).
  • 3
  • [ 1458-63-5 ]
  • [ 18372-22-0 ]
  • [ 1443138-41-7 ]
 

Historical Records

Technical Information

Categories